|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
It was reported that a patient was co-sleeping with parents and using a spo2 monitoring device when the patient passed away while sleeping overnight.The family stated that the device did not alarm at the time of the patient's death.The patient, a 2-month-old female weighing 4 kg, was experiencing respiratory distress syndrome of newborns.
|